nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—DRD3—Dopamine receptors—DRD4—conduct disorder	0.107	0.141	CbGpPWpGaD
Domperidone—DRD2—Dopamine receptors—DRD4—conduct disorder	0.082	0.108	CbGpPWpGaD
Domperidone—Sertindole—DRD4—conduct disorder	0.048	0.201	CrCbGaD
Domperidone—Droperidol—HTR2A—conduct disorder	0.0343	0.144	CrCbGaD
Domperidone—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.034	0.0447	CbGpPWpGaD
Domperidone—Sertindole—SLC6A4—conduct disorder	0.0288	0.12	CrCbGaD
Domperidone—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.026	0.0342	CbGpPWpGaD
Domperidone—DRD3—Monoamine GPCRs—DRD4—conduct disorder	0.0237	0.0311	CbGpPWpGaD
Domperidone—Sertindole—HTR2A—conduct disorder	0.0221	0.0925	CrCbGaD
Domperidone—DRD3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0199	0.0262	CbGpPWpGaD
Domperidone—CYP1A2—Methylation—COMT—conduct disorder	0.0188	0.0247	CbGpPWpGaD
Domperidone—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0186	0.0244	CbGpPWpGaD
Domperidone—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.0181	0.0238	CbGpPWpGaD
Domperidone—Nefazodone—SLC6A4—conduct disorder	0.0174	0.0729	CrCbGaD
Domperidone—Trazodone—SLC6A4—conduct disorder	0.0161	0.0675	CrCbGaD
Domperidone—DRD3—Monoamine GPCRs—HTR2A—conduct disorder	0.0155	0.0203	CbGpPWpGaD
Domperidone—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0152	0.02	CbGpPWpGaD
Domperidone—Pimozide—HTR2A—conduct disorder	0.0135	0.0564	CrCbGaD
Domperidone—Zuclopenthixol—HTR2A—conduct disorder	0.0135	0.0564	CrCbGaD
Domperidone—Nefazodone—HTR2A—conduct disorder	0.0134	0.0561	CrCbGaD
Domperidone—DRD3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.013	0.0171	CbGpPWpGaD
Domperidone—Trazodone—HTR2A—conduct disorder	0.0124	0.0519	CrCbGaD
Domperidone—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.0118	0.0156	CbGpPWpGaD
Domperidone—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0117	0.0154	CbGpPWpGaD
Domperidone—Pipotiazine—HTR2A—conduct disorder	0.0116	0.0486	CrCbGaD
Domperidone—DRD3—GPCRs, Other—DRD4—conduct disorder	0.0105	0.0138	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0101	0.0133	CbGpPWpGaD
Domperidone—KCNH2—Neuronal System—GABRA2—conduct disorder	0.00999	0.0131	CbGpPWpGaD
Domperidone—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00994	0.0131	CbGpPWpGaD
Domperidone—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00939	0.0123	CbGpPWpGaD
Domperidone—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00905	0.0119	CbGpPWpGaD
Domperidone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00828	0.0109	CbGpPWpGaD
Domperidone—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00795	0.0105	CbGpPWpGaD
Domperidone—Perphenazine—HTR2A—conduct disorder	0.00795	0.0332	CrCbGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0076	0.01	CbGpPWpGaD
Domperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.007	0.0092	CbGpPWpGaD
Domperidone—DRD3—GPCRs, Other—HTR2A—conduct disorder	0.00687	0.00903	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0062	0.00815	CbGpPWpGaD
Domperidone—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00612	0.00804	CbGpPWpGaD
Domperidone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00598	0.00786	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—SLC6A4—conduct disorder	0.00594	0.00781	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—DRD4—conduct disorder	0.00558	0.00734	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00535	0.00704	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—CGA—conduct disorder	0.00533	0.007	CbGpPWpGaD
Domperidone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00518	0.00681	CbGpPWpGaD
Domperidone—DRD3—G alpha (i) signalling events—DRD4—conduct disorder	0.00493	0.00648	CbGpPWpGaD
Domperidone—KCNH2—Neuronal System—COMT—conduct disorder	0.00481	0.00632	CbGpPWpGaD
Domperidone—KCNH2—Neuronal System—MAOA—conduct disorder	0.00478	0.00628	CbGpPWpGaD
Domperidone—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00457	0.00601	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00454	0.00597	CbGpPWpGaD
Domperidone—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00443	0.00582	CbGpPWpGaD
Domperidone—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.0044	0.00578	CbGpPWpGaD
Domperidone—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00437	0.00574	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.00427	0.00562	CbGpPWpGaD
Domperidone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00425	0.00559	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—CGA—conduct disorder	0.00408	0.00536	CbGpPWpGaD
Domperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00392	0.00515	CbGpPWpGaD
Domperidone—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.00377	0.00496	CbGpPWpGaD
Domperidone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0036	0.00474	CbGpPWpGaD
Domperidone—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0035	0.0046	CbGpPWpGaD
Domperidone—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.0033	0.00433	CbGpPWpGaD
Domperidone—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00328	0.00432	CbGpPWpGaD
Domperidone—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00327	0.0043	CbGpPWpGaD
Domperidone—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00325	0.00427	CbGpPWpGaD
Domperidone—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00323	0.00424	CbGpPWpGaD
Domperidone—CYP3A5—Biological oxidations—COMT—conduct disorder	0.0032	0.00421	CbGpPWpGaD
Domperidone—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00318	0.00418	CbGpPWpGaD
Domperidone—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00316	0.00415	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.00301	0.00396	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.003	0.00394	CbGpPWpGaD
Domperidone—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00298	0.00392	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.00298	0.00392	CbGpPWpGaD
Domperidone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00278	0.00366	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00277	0.00364	CbGpPWpGaD
Domperidone—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00275	0.00362	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—CGA—conduct disorder	0.00273	0.00359	CbGpPWpGaD
Domperidone—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00273	0.00359	CbGpPWpGaD
Domperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00256	0.00336	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00237	0.00312	CbGpPWpGaD
Domperidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00237	0.00312	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00236	0.0031	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.0023	0.00303	CbGpPWpGaD
Domperidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00228	0.003	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.00228	0.003	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00228	0.00299	CbGpPWpGaD
Domperidone—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00226	0.00297	CbGpPWpGaD
Domperidone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00224	0.00295	CbGpPWpGaD
Domperidone—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00223	0.00293	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CGA—conduct disorder	0.00209	0.00275	CbGpPWpGaD
Domperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00196	0.00257	CbGpPWpGaD
Domperidone—DRD3—GPCR ligand binding—HTR2A—conduct disorder	0.00195	0.00256	CbGpPWpGaD
Domperidone—DRD3—Circadian rythm related genes—EP300—conduct disorder	0.00193	0.00254	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00193	0.00253	CbGpPWpGaD
Domperidone—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00191	0.00252	CbGpPWpGaD
Domperidone—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.0019	0.0025	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00183	0.00241	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—DRD4—conduct disorder	0.00169	0.00222	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CGA—conduct disorder	0.00168	0.0022	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00164	0.00216	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CGA—conduct disorder	0.00162	0.00212	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—DRD4—conduct disorder	0.00153	0.00201	CbGpPWpGaD
Domperidone—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.00149	0.00196	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00149	0.00196	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00148	0.00194	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.00148	0.00194	CbGpPWpGaD
Domperidone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00147	0.00193	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—WASF1—conduct disorder	0.00129	0.0017	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.00129	0.0017	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CGA—conduct disorder	0.00124	0.00163	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CGA—conduct disorder	0.00124	0.00162	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CGA—conduct disorder	0.00121	0.00159	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—DRD4—conduct disorder	0.00117	0.00154	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	0.0011	0.00145	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CGA—conduct disorder	0.00105	0.00138	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—HTR2A—conduct disorder	0.000999	0.00131	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—WASF1—conduct disorder	0.00099	0.0013	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000952	0.00125	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CGA—conduct disorder	0.000915	0.0012	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—DRD4—conduct disorder	0.000904	0.00119	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CGA—conduct disorder	0.000862	0.00113	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	0.000842	0.00111	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—HTR2A—conduct disorder	0.000764	0.001	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—COMT—conduct disorder	0.000757	0.000995	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—MAOA—conduct disorder	0.000752	0.000988	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CGA—conduct disorder	0.00073	0.00096	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—DRD4—conduct disorder	0.000692	0.00091	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HTR2A—conduct disorder	0.00059	0.000776	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CGA—conduct disorder	0.000564	0.000741	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—COMT—conduct disorder	0.00056	0.000736	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—MAOA—conduct disorder	0.000556	0.000731	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—COMT—conduct disorder	0.000547	0.000719	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—MAOA—conduct disorder	0.000543	0.000714	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—COMT—conduct disorder	0.000474	0.000623	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—MAOA—conduct disorder	0.000471	0.000619	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000456	0.0006	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HTR2A—conduct disorder	0.000452	0.000594	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—COMT—conduct disorder	0.000413	0.000543	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—MAOA—conduct disorder	0.00041	0.000539	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—COMT—conduct disorder	0.000389	0.000512	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—MAOA—conduct disorder	0.000386	0.000508	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—COMT—conduct disorder	0.00033	0.000433	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—MAOA—conduct disorder	0.000327	0.00043	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—EP300—conduct disorder	0.000325	0.000427	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000317	0.000417	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EP300—conduct disorder	0.000313	0.000411	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—COMT—conduct disorder	0.000254	0.000334	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MAOA—conduct disorder	0.000253	0.000332	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—EP300—conduct disorder	0.00024	0.000316	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EP300—conduct disorder	0.000239	0.000314	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—EP300—conduct disorder	0.000235	0.000309	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—EP300—conduct disorder	0.000203	0.000267	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—EP300—conduct disorder	0.000177	0.000233	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—EP300—conduct disorder	0.000167	0.000219	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—EP300—conduct disorder	0.000141	0.000186	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—EP300—conduct disorder	0.000109	0.000143	CbGpPWpGaD
